Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Monthly Archives: November 2013

Research Shows: Presence of Bacteria in the Gut are Important in Combating Cancer

Posted in Drug Studies

Published Thursday, scientists at the National Cancer Institute wrote an article called “NIH Mouse Study Finds Gut Microorganisms May Determine Cancer Treatment Outcomes”.  The National Cancer Institute believes they may have found a connection between the presence of certain organisms living in the human gut and the success of cancer therapy.  Mice that had cancerous… Continue Reading

FBI Steps Up Defenses for Attacks on US Food Supply

Posted in FDA Regulation, Public Health

Ellen Beck recently wrote an article for the “Smart Blog on Food and Beverage” website titled “FBI Makes Threats to U.S. Food Supply a Bigger Priority”, that discusses the food industry’s vulnerability to intentional food contamination.  In light of all the terrorist attacks taking place throughout the world, the FBI is becoming increasingly concerned that… Continue Reading

FDA approves new cancer drug Crizotinib

Posted in Drug Studies, Public Health

In an article published from the Oncology Report Digital Network by Elizabeth Mechcatie, titled “FDA Grants Full Approval to Crizotinib for NSCLC Indication”, the Food and Drug Administration announced that a new drug was approved for the treatment of small cell lung cancer.  Crizotinib is a kinase inhibitor that works by blocking the actions of… Continue Reading

Reuters: Curis Places Testing of New Cancer Drug On Hold

Posted in Drug Studies

Last Wednesday (11/6/2013), Reuters reported that the approval of a new cancer drug by Curis Inc. has stalled after a patient died while taking the drug. Curis Inc. is a company that develops many new drugs used for in cancer treatment.  In collaboration with other major drug companies, Curis created Erivedge, the only medication for… Continue Reading

WARNING: FDA recall on OxyElite Pro due to connection with “serious adverse health consequences, namely serious liver damage or acute liver failure”

Posted in Public Health, Recalls

On 11-9-2013, the FDA announced a recall of dietary supplement OxyElite Pro (USPlabs LLC, Dallas) “after officials linked it to cases of liver failure and acute hepatitis in 29 people” in Hawaii, CNN reports. Several sources now report that one of two patients who required liver transplants has died.  WebMD writes that other people “are… Continue Reading

FDA moves to ban trans fats – New York Times

Posted in FDA Regulation, Public Health

A November 7th New York Times article by Sabrina Tavernise discusses the recent FDA ruling surrounding trans fats. Nutrition is an ever-changing area of research.  Many of the guides to healthy cooking and eating methods once thought ideal are now seen to be quite unhealthy and harmful to our health.  During the 1950’s, 1960’s, and… Continue Reading

FDA finds Drug Quality and Security Act insufficient

Posted in FDA Regulation

Julian Hattem of RegWatch, a blog curated by TheHill, reports in a piece that the US Food and Drug Administration is “not sold” on a recent pharmacy compounding bill. The mixing and distributing of medications happens at various compound pharmacy clinics found all throughout the United States, and these compounding clinics have been the source… Continue Reading

FDA seeks more stringent controls for some pain medications

Posted in FDA Regulation, Public Health

According to a recent report by HealthToday.com, The U.S. Food and Drug Administration believes certain commonly-used drugs that should be more difficult to obtain.  Painkillers such as Lortab and Vicodin contain hydrocodone (a synthetic opiate) which is often abused and highly addictive; tighter controls on these types of prescriptions may be a good way to… Continue Reading

2012 – SSRIs associated with spontaneous abortion

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

Studies have shown that women suffering from depression during pregnancy can put the child at risk of developing malformations.  As such, selective serotonin reuptake inhibitors (SSRIs) are most commonly prescribed to the mother to avoid such complications.  Unfortunately, using these drugs during pregnancy may also put the child at risk of malformations.  To date, the… Continue Reading

2008 – High rate of complications, secondary surgeries seen with penile implants from American Medical Systems

Posted in Penile Implants

We are no longer accepting cases regarding these products.  Due to a terrible Supreme Court ruling, consumers injured by this product are no longer permitted to sue the manufacturers of this device.  We wish we could help, but the Supreme Court has taken the rights of citizens away to protect the profits of medical device… Continue Reading

Johnson and Johnson $2.2B Settlement for Illegal Marketing, Corruption

Posted in Lawsuits

As of November 4th, Johnson & Johnson agreed to a $2.2 billion deal in the settlement of pending criminal and civil charges that “alleged the healthcare giant illegally marketed its Risperal antipsychotic [along with Invega and Natrecor], and also paid kickbacks to physicians and Omnicare, the largest nursing home/pharmacy [company in the US,] to boost… Continue Reading

E. Coli Outbreak in Knox County, Tennessee

Posted in Public Health

A Knox County, Tennessee dairy farm has recently come under harsh scrutiny since an E. coli outbreak hit Mascot last Thursday.  Health officials have reported that a few children have become sick from the E. coli outbreak and that the proper authorities will contact anyone who may have exposed.  Investigators collected samples from the farm… Continue Reading